Cyclopentolate is a prescription ophthalmic solution used to temporarily paralyze the eye’s focusing muscle (cycloplegia) and to widen the pupil (mydriasis) for diagnostic examinations. It belongs to the class of anticholinergic eye drops and is supplied in a 1 % concentration as a sterile drop. In Hong Kong, cyclopentolate is regulated by the Department of Health and is available only with a medical prescription.
Cyclopentolate blocks muscarinic acetylcholine receptors in the iris sphincter and ciliary body. By inhibiting these receptors:
The drug is applied directly to the ocular surface, and only a small fraction is absorbed systemically. Onset of action typically occurs within 15-30 minutes, with maximal pupil dilation reached in 30-60 minutes. The effects gradually wear off over 6-24 hours as the drug is metabolized by ocular tissues and cleared through the nasolacrimal system.
Cyclopentolate is approved for use in the following situations:
In Hong Kong, these uses align with local ophthalmology practice guidelines. Cyclopentolate is not indicated for therapeutic treatment of eye diseases such as glaucoma or uveitis.
These effects are usually short-lived and resolve without intervention.
If any of these serious signs occur, seek immediate medical attention.
Patients should disclose all eye medications, systemic drugs, and over-the-counter supplements to their eye care provider before cyclopentolate use.
If a dose is missed during a scheduled examination, the procedure should be rescheduled rather than attempting to double the dose.
Signs of overdose include pronounced dry mouth, flushing, rapid heart rate, and severe blurred vision. Management is supportive; seek emergency care, and inform clinicians of cyclopentolate exposure.
Cyclopentolate is used only for short examinations; no tapering is required. Discontinue use once the diagnostic procedure is complete.
This article provides educational information about cyclopentolate and is not a substitute for professional medical advice. Treatment decisions, including the use of any medication for unapproved purposes, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Yes. Because cyclopentolate dilates the pupil and can blur near vision, you should avoid driving or operating heavy machinery until your vision returns to normal, typically a few hours after the drop is administered.
In Hong Kong, ophthalmic solutions are usually packaged in amber glass vials or plastic droppers with printed information in English and Chinese. The label includes the drug name, concentration (1 %), volume, batch number, expiry date, and the prescribing authority’s registration number.
Cyclopentolate is not a controlled substance and is not included in standard workplace drug-screening panels. However, its anticholinergic properties could theoretically be detected in specialized toxicology assays, though this is uncommon.
Contact lenses should be removed before instilling cyclopentolate drops to ensure proper drug delivery and to avoid trapping the solution between the lens and cornea. Re-insert lenses only after the drug’s effect has worn off and any residual liquid has been cleared.
Both are anticholinergic agents, but cyclopentolate has a shorter duration of action (6-24 hours) compared with atropine, which can last up to several days. Cyclopentolate is preferred for routine diagnostic dilation, while atropine is reserved for therapeutic situations requiring prolonged mydriasis.
Cyclopentolate was first synthesized in the 1950s as a short-acting muscarinic antagonist for ophthalmic use. Clinical trials in the 1960s established its safety profile for cycloplegic examinations, leading to widespread adoption in eye care worldwide.
Generic cyclopentolate drops are typically less expensive than brand-name mydriatics such as tropicamide or phenylephrine-based combinations. Prices can vary depending on pharmacy purchasing agreements and whether the product is sourced from local distributors or imported.
The product is stable at room temperature; refrigeration is not required and may cause condensation that affects sterility. Store it in a cool, dry place away from direct sunlight.
Severe eye pain could signal acute angle-closure glaucoma, a medical emergency. Seek immediate ophthalmic evaluation or go to the nearest emergency department.
Cyclopentolate is primarily used for diagnostic purposes. For intra-operative dilation, longer-acting agents like phenylephrine or combination preparations are preferred.
